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Abstract
Background: There is often a great urgency to be inclusive when conducting research and to focus efforts with
groups and communities that can be referred to as marginalised. This is especially the case in research concerning
medical devices aimed at children and young people (CYP). Although involvement methodology has developed
over the last two decades, it can be challenging to involve and engage CYP with confidence and clarity of purpose.
Main body: Our aim was to provide a reflective narrative account of the involvement of CYP, over a period of 5
years, in a research project from conception of a new paediatric medical device through to practical application.
We explored a model of patient and public involvement (PPI) through the Nottingham Young Persons Advisory
Group (YPAG), part of the National Institute for Health Research (NIHR) GenerationR Alliance, in a NIHR funded
research project.
The YPAG designed and created a model of the human gut, co-designed the Transicap™ mini-capsules and their
packaging, co-produced patient information sheets, came up with the idea to disseminate through a project
website and co-wrote and created animation videos. The YPAG involvement continued through the writing and
award of the follow-on research grant (MAGIC2). During this process the YPAG modified the clinical study protocol
insisting that all participants in the control arm were given the imaging test results as well, save for a delayed
reading compared to the intervention arm.
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Conclusion: Involvement of the YPAG over the last 5 years, led to the development of a mutually beneficial
partnership, enabling genuine knowledge exchange between researchers and CYP. This influenced the design,
plans and actions of the MAGIC study and well into the subsequent MAGIC2 follow-on project. Moreover, these
involvement models applied within a feasibility study setting, have enhanced the realism and pragmatism of the
study, contributing to the project’s overall success.
Keywords: Patient and public involvement (PPI), Involvement, Young persons advisory group (YPAG), Children and
young people (CYP), Children and young people in research, GenerationR
Plain English summary
Sharing experiences and the influence of involvement
in research are important in helping make research
studies better. This manuscript aimed to share our
experiences of involving a group of Children and
Young People (CYP) in our research. Over the past 5
years a small group of CYP across Nottingham,
namely the Young Persons Advisory Group (YPAG),
has worked with the ‘MAGIC’ study. This is a re-
search project sponsored by the National Institute for
Health Research aiming to develop a new medical im-
aging test for children suffering from long term con-
stipation. For the researchers this was their first
experience of involving children and young people in
research. With time their involvement developed into
a mutually beneficial partnership, enhancing the suc-
cess of the research project and the experiences of
those involved. From the initial idea of a new medical
imaging device through to study completion, the
YPAG meetings involved practical, creative, hands-on
activities such as creating animations and working
models of the human gut. We believe that involving
CYP in research benefitted both the research study
with real patient experiences as well as giving the
CYP the opportunity to express those experiences and
put them to good use.
Background
Since September 2014 to date, a group of children and
young people (CYP) from the National Institute for
Health Research (NIHR) Nottingham GenerationR
(https://generationr.org.uk/) Young Persons Advisory
Group (YPAG) have been involved with the ‘MAGIC’
study. MAGIC is a research project aiming to develop a
new mini-capsules medical imaging device to measure
gut transit in paediatric constipation. The project is
funded by the NIHR with GenerationR Alliance support-
ing the design and delivery of paediatric health research
in the UK. The MAGIC study findings have been re-
cently published in a separate manuscript which details
the design of the new mini-capsules device and the sci-
entific details of the feasibility clinical study [1]. The
main features of the MAGIC study are summarised in
Table 1.
The purpose of this Commentary is to share our case
study of an unusually long involvement of a group of
CYP in a medical device development project, from an
early stage through to completion and to describe how
this can have a positive effect on the study, the re-
searchers involved and the YPAG.
The Nottingham YPAG group consisted of CYP
aged between 8 and 18 years. The aims of the group
were to advise researchers on whether their intended
project and methods were acceptable for the inclusion
of children, to interact with the technology designers,
as well as developing relevant and appropriate lan-
guage for research tools [12]. However, over time the
Nottingham YPAG involvement grew far beyond this,
expanding their remit as their relationship strength-
ened through shared endeavour. The Nottingham
YPAG supported the MAGIC study as well as re-
search across several other fields of paediatric re-
search. For the MAGIC study researchers this was
their first experience of working with a YPAG. From
the onset of the MAGIC study, the researchers made
a commitment to attend YPAG meetings on regular
occasions, to ensure the group were involved and
kept up to date, from start to finish of the project.
This resulted in learning as much for the researchers
as for the YPAG themselves.
Definition and theoretical underpinnings
Treseder defined the participation of children in re-
search as “a process by which CYP influence decisions
which bring about change in themselves, their peers, the
services they use and communities” [13].
The definition of involvement and participation how-
ever, are often confused and used inappropriately. In
participation the partaker has no say in decision making,
whereas in involvement the partaker is fully immersed in
discussion, collaboration, decision making and holds
parity. Brady and Graham highlighted the benefits of
CYP involvement, by saying it gives them the opportun-
ity to voice their opinions forming a collation of
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knowledge from the younger generation, making a con-
tribution to their community, develop transferable skills,
social skills as well as confidence, self-esteem and know-
ledge [12].
Numerous models described the various levels of
involvement with children. Shier discussed 5 levels of
involvement and decision making, including: Children
being listened to; Supporting children in their views;
Utilising the views of children; Children involved in
decision making, and Children having equal power
[14]. Likewise, Hart’s “Ladder of participation” showed
the distinction between non-participation and the
various degrees of participation by children, moving
from manipulation, decoration, tokenism, through to
informed, consulted involvement and on to shared de-
cision making and child led initiatives [15]. Research
funders commonly request involvement from the pub-
lic and wider community as they recognise it
strengthens the research and better reflects the reality
of patients living with conditions [16–18]. In the past
paediatric research might have enlisted adults as
members who would communicate their interpret-
ation of CYP’s thoughts, feelings and ideas by acting
as proxies. The United Nations Convention on the
Rights of the Child stressed strongly that children
have a voice too, especially in matters which affect
them, and therefore proxies are not needed; the chil-
dren can represent themselves. The increased expect-
ation to involve the public in research is supported
by Fleming and Boeck, who noted research should
directly reflect the personal priorities, concerns and
therefore the actual needs of CYP [19]. Riggare et al.
described PPI participants as patient advocates having
experiential knowledge of their condition and should
thus be treated with the same regard as other experts
in their field [20, 21].
Patient and Public Involvement (PPI) can result in
better design, dissemination, awareness of the study
leading to changes in the care patients receive and
triggering policy change [12, 18]. PPI can not only
help to shape the practical details of research but also
change the attitude of the researchers and medical
experts themselves. However, the practice of involving
CYP as collaborators in research although widely ad-
vocated, is still evolving and largely driven by aca-
demic professionals [22].
Aims of involvement
Our initial objective was to meaningfully involve CYP
to improve the design and acceptability of the MAGI
C feasibility study (Table 1). We aimed to co-design
the Transicap™ mini-capsules and packaging with the
YPAG to ensure acceptability by our paediatric pa-
tient population. We also wanted feedback on percep-
tions of study outcomes, so that they reflected the
priorities of CYP, as the study design included
unavoidable medical procedures such as Magnetic
Resonance Imaging (MRI) and the swallowing of
mini-capsules on specific days. We asked the YPAG
to be involved in developing information leaflets and
study documentation that would be relevant to young
patients and essential for study recruitment. Figure 1
below shows the timeline of activities and further de-
tails can be found in Appendix 1.
Table 1 The MAGIC Study and The TransiCap™ Medical Device
The clinical background of the MAGIC study is paediatric constipation
and the project was funded by a NIHR Invention for Innovation (i4i)
Product Development Award grant. Constipation in children is a
common and often distressing problem and is termed functional
constipation when no underlying cause can be detected. Functional
constipation prevalence worldwide is estimated between 4 and 36%,
with 34% of children in Britain aged 4–11 years reported to have had
constipation. The cost to the healthcare system is high, at ~$3.9 billion/
year [2–8].
Management of these children is difficult and based mostly on
symptom reports [9, 10]. The existing method to measure gut transit
time (the time it takes for food to move through the gut) involves
ingesting plastic pellets and taking X-ray images [11]. However, X-ray im-
ages are unable to reveal the colon anatomy well and provide a harmful
radiation dose. The research team sought to find a modern alternative
to the old X-ray method by designing a similar method of measuring
gut transit time but using magnetic resonance imaging (MRI). MRI has
better image quality than X-rays and uses no harmful radiation and is
therefore the preferred choice when imaging children.
In this project the research team designed and manufactured new,
small plastic capsules filled with liquid that can be seen by MRI. The
capsules are only a few millimetres long and are easy for young people
to swallow. They do not dissolve in the body but travel along the gut,
where they can be imaged using a quick MRI scan. The TransiCap™
mini-capsules (now patented and trademarked) are a medical device
manufactured by JEB Technologies Ltd. (UK).
The team obtained all necessary Ethics and regulatory approvals and ran
a ‘first-in-child’ feasibility clinical study of the mini-capsules in young pa-
tients with constipation and healthy controls. The study recruited 35
children between 7 and 18 years old. On day 1, 2 and 3 of the study the
participants swallowed 24 mini-capsules and on day 4, 7 and 28 they
had a quick 15min MRI scan to locate the position of the mini-capsules.
We confirmed that the mini-capsules can be swallowed easily by 35
young people and successfully imaged in the gut using MRI to deter-
mine their gut transit time.
The research team were then successful in obtaining a second NIHR i4i
grant award for the follow-on work, MAGIC2. MAGIC2 is a large multi-
centre clinical trial across 8 hospitals in the UK recruiting 436 young
constipated patients to assess if using the mini-capsules MRI gut transit
time test can improve treatment success. Participants will be asked to
swallow 24 mini-capsules each day for 3 days and then have an MRI
scan on days 4 and 7. All participants will be randomly assigned to two
groups. An intervention group will receive their gut transit time results
immediately after the day 7 MRI scan; the results will thus be available
to guide treatment selection. A control group will also have the day 7
MRI scan but the results will not be shared with their care team until
the end of the trial; their treatment selection will not be guided by the
MRI results. The results will only be delayed so that a proper comparison
with the intervention group can be made. Computer software that can
detect the mini-capsules semi-automatically will also be designed.
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The aim of this manuscript was to share our experi-
ences and to encourage research investigators embarking
on a research project concerning CYP not just to involve
them as needed but to build a long term mutually bene-
ficial relationship.
Main body
Using GRIPP2 [23] as our reference guide we wished to
share an account of the YPAG engagement sessions and
activities the CYP took part in. The YPAG involvement
process in the MAGIC project is summarised in the dia-
gram at Fig. 2 and detailed in the subsequent
paragraphs.
YPAG meetings and members
Over the last 5 years there were 13 sessions in which
the YPAG was involved in aspects of the MAGIC
study and these were attended by an average of 16
CYP. Our YPAG members had a broad age range;
18% 8–11 year olds, 37% 12–15 year olds and 45%
16–18 year olds. The YPAG group consisted of a
group of CYP for whom no inclusion and no exclu-
sion criteria were set, no assumptions were made
and we did not exclude anybody who wished to par-
ticipate. Over the 5 years the group had a 69% reten-
tion rate. This retention rate shows the number of
CYP who attended the YPAG meetings and stayed
for the entire 5 years. It reflects a level of commit-
ment of the majority of CYP, and this can be inter-
preted as commitment from the YPAG to paediatric
research as a whole, and also a desire for personal
development, which can be seen in the semi-
structured interview transcript in Appendix 2. The
broad age range matched the age range of the pa-
tient population which we intended to recruit into
the MAGIC study. Ocloo and Matthews raise con-
cerns that PPI groups may be insufficiently inclusive
and so groups for example from black, Asian, minor-
ity and ethnic populations are kept at a distance
from decision making even though those decisions
may disproportionately affect them [24]. Poland
et al. concurred the size of the PPI group is insig-
nificant, the diversity of the attenders is the crucial
factor to capture the varied experiences giving the
researcher an insight they don’t have [25]. The
members of the Nottingham YPAG were recruited
widely and with no selection criteria, assumptions or
interviews. Looking back at our historical member-
ship we have indeed included members across all
age range, different ethnicity and socioeconomic
background, some from the general population and
schools, some from out-patient clinics and some
from participants to research studies. All members
of the Nottingham YPAG were allowed to be in-
volved and contribute to all the research studies put
in front of them. The group consisted of CYP who
were interested and wanted to make a positive con-
tribution to paediatric research, a genuine mix of
CYP brought together with a common interest in re-
search, not a group specifically focussed on CYP
with constipation.
Safeguarding
The YPAG group leaders were adult PPI experts from
Nottingham University Hospitals (NUH). All were
Disclosure and Barring Service (DBS) checked, fully in-
formed of the research projects and tasks for each YPAG
session and interested in the views of young people and
their involvement. All decisions concerning the func-
tionality of the YPAG sessions were mutually agreed
with the CYP. The group leaders are hereafter referred
to as facilitators rather than leaders as their objective
during the sessions was to guide the YPAG group rather
than direct and persuade them.
Fig. 1 Timeline of YPAG MAGIC activities
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Laying the foundations for MAGIC and YPAG co-
production
All activities during the YPAG sessions were specific-
ally designed to engage the participants, encourage in-
clusivity and freedom of ideas. Ground rules were co-
produced with the YPAG, encouraging a respectful
and safe environment. Furthermore feedback after
each session led to continuous development of session
activities, including changes to the location of the
YPAG session, from hospital based to locations within
the community and University of Nottingham cam-
pus. Above all the YPAG vocalised that communica-
tion between researchers, facilitators and themselves
was paramount. This is reflected in the transcript of
an interview carried out as part of the YPAG’s feed-
back and dissemination activities in Appendix 2. The
facilitator’s job during the YPAG sessions was purely
to guide and support the members of the YPAG.
They encouraged critical thinking, free expression of
ideas and assisted discussion. The activities were en-
gaging, child friendly, imaginative and fun. The ses-
sions were devised by the group facilitators, but
directed by the children’s own ideas of what they
wanted to do. Hart commented that the limitation to
research involving CYP is their competence, maturity
and understanding which develops with age [26]. Our
activities were adapted to ensure that every member
of the group could participate regardless of their age
or level of literacy or numeracy. All meetings were
held at the weekend to not disrupt school life and
were not scheduled too often to ensure school work,
school holidays and their social life was not too af-
fected. All children under the age of 16 were signed
in and out by their parent/guardian on the day of the
YPAG sessions. The consent process was developed
by NUH to provide a standard and relatively simple
process, whilst also ensuring parents and CYP were
informed about the functionality of the YPAG. Infor-
mation sheets were provided to both parents/carers
and the CYP, who both gave consent and also con-
sented for use of photos and media materials for dis-
semination. Full support was available if any queries
during the process and the participation. Further,
each YPAG participant provided evidence of allergies
Fig. 2 Diagram of the YPAG involvement process in the MAGIC project
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in relation to the catering we provided at each meet-
ing, plus information relating to any medications they
needed to take and emergency contact telephone
numbers.
YPAG tasks – the ‘pipework gut’
The first task the YPAG group approached was to con-
sider the structure of the gastrointestinal tract and the
journey the mini-capsules would be taking after the par-
ticipants of the study had swallowed them. To ‘tune in’
we asked the group to build a marble run as a full scale
‘pipework gut’ using a variety of drain pipes, connectors
and supports from a hardware store. This enabled the
group to learn how food moved from the start (mouth)
to the end (bottom) and what might prevent normal
flow. The rationale behind this activity was to introduce
the MAGIC study and what happens during constipation
and to ensure everyone from any age within the group
could fully understand the physiology of the human
gastrointestinal tract. We also wanted to produce a 3D
model which could be used for future demonstrations.
This task also acted as an ice breaker for the YPAG and
the MAGIC study research team. This was a hands-on
task, where cooperation was key to the construction of
the ‘pipework gut’, whereby researchers and YPAG
group members worked side by side to build the final
structure. Non Latin/Greek anatomical language was
used during this task to promote inclusivity of all mem-
bers of the team. The ‘pipework gut’ has been subse-
quently used at several public engagement events,
including the ‘Wonder’ event of May 2019 for the Uni-
versity of Nottingham. As a research team we now try to
find more imaginative ways of helping people under-
stand research.
YPAG tasks – design of the mini-capsules device
Their second task in hand was to help with the design of
the mini-capsules. The YPAG group were asked to con-
sider the size, shape of the capsules and the method in
which they would prefer to swallow them.
The designing of the mini- capsules and the packaging
was done in collaboration with medical device designers
Renfrew Group International and the research team. The
feedback from the device designs consultation with the
YPAG lead us to develop a smaller, smoother, more
rounded mini-capsule design. The YPAG agreed special
tablet shapes, in the shape of characters, hearts, flower
shapes etc., which might be more appealing to children,
could prove difficult to swallow and would not be pre-
ferred and also the capsules must remain flavourless. The
YPAG gave further instruction from their own personal
experiences, by commenting on the method children
should swallow the capsules, by using fruit juices or milk
to mask the unfamiliar taste and texture of the capsules.
YPAG tasks – design of the mini-capsules packaging
Thirdly the YPAG were invited to co-design the
mini-capsules’ packaging. They were given mock up
capsules and a range of food boxes and packaging,
and worked in groups to design how the mini-
capsules would be packaged. They were asked to con-
sider current packaging of medical devises and if
there was a way of making the packaging more child
friendly. They had to consider how many capsules
would be packed, whether altogether, in blister packs
separately or any other form they might have seen
from their own experiences. Again the YPAG worked
with the designers from Renfrew Group International,
who attended a YPAG meeting. We worked all to-
gether on ideas that were subsequently drawn profes-
sionally and brought back to the YPAG group for
discussion and feedback. The YPAG suggested separ-
ating the capsules out into three portions; each por-
tion containing the number of mini capsules to be
swallowed over the 3 days of the study. The YPAG
proposed a yogurt pot packaging style, where three
pots would be joined in series and each pot contained
24 mini-capsules in each. The child then simply broke
one pot off each day, unpeeled the lid and used the
pot to pour the contents into their mouth for swal-
lowing. At the time, the work necessary to validate
the new proposed blister pack (or yoghurt pot style)
packaging for regulatory purposes could have caused
delays to the clinical trial set up and approvals. Upon
further consultation with the YPAG they proposed
the three portions should have the ability to be
stacked on top of each other and packaged together
within a box which could easily fit into a child’s
pocket. Figure 3 shows examples of the YPAG ideas
of mini-capsules’ packaging through to designers’
sketches and to real manufacturing prototypes along
with Renfrew Group International designers’ interpret-
ation of the YPAG pouch suggestion. Upon hearing
the ideas from the YPAG, the manufacturer (JEB
Technologies Ltd.) subsequently changed the pack-
aging to pouches, as this was a method that could
satisfy regulatory validation more easily and met the
needs proposed by the YPAG. The evidence from the
YPAG meeting suggested this was a recognised pack-
aging solution, easily usable and identifiable with chil-
dren. The direct effect of the involvement is the
chosen packaging system used for the Transicap™
mini capsules feasibility study. The development of
the yogurt pot packaging style is currently progressing
for the future product packaging needs.
YPAG tasks – design of participant information sheets
The group were then asked to work together to devise
patient and parent/carer information sheets (PIS) to be
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given to the MAGIC participants. They were asked to
think about what information the participants and their
parents/carers would need to know about the study, the
language used in the information sheets and the format
in which the information should be presented. A further
task was to review the actual participant and parent/
carer PISs developed by the researchers according to the
previous discussions. They were asked to give feedback
on clarity, content, layout, age groups targeted (either
adult or child), use of language and appropriateness for
the age groups to understand what was being asked of
them, and how much information should be included in
the participants PIS and their parents/carer PIS. For this
purpose, some of the YPAG sessions were devoted to
writing and/or reviewing patient information sheets,
consent forms, assent forms, health questions etc. A sug-
gestion by a member of the YPAG was to create separate
PIS’s for different age ranges within our participant
population. They felt that children should have the study
explained to them at their level, rather than being pre-
sented with a generic patient information sheet written
by adults for an adult audience. PIS’s were therefore
written for 7–9, 10–12, 13–15 and 16–18 year olds. All
documents were written by the research team then edi-
ted by the YPAG so they were worded slightly differ-
ently, increasing in complexity of language with age. The
YPAG also commented on increasing the line spacing
for younger patient information sheets, to make it easier
for younger participants to read (Fig. 4). The PISs for
the younger groups were much shorter than those for
the older groups, only containing specific information
which was relevant to the child. This again was a sugges-
tion by the YPAG as they felt a younger child may have
a shorter attention span and not be able to cope with
reading larger documents of information. The conse-
quences of the involvement meant our information
Fig. 3 Examples of translation of YPAG ideas of mini-capsules’ packaging through designers’ sketches and to real manufacturing prototypes. a
YPAG’s play-for-learning suggestion to use three separate round pots, b the designers’ sketch of what this could look line with cardboard box
and c the corresponding real packaging prototype developed by the manufacturer. This type of packaging was further developed and went into
actual use in the feasibility study. d An alternative YPAG suggestion was to use sachets represented with the designers’ sketch in (d). This design
evolved into the real packaging (e) which is to be used in the follow-on clinical trial MAGIC2
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sheets were more understandable. Both the patient in-
formation sheets and assent forms were reviewed and
praised by the Ethics committee for their inclusivity.
YPAG tasks – design of animated videos, study website
and presentations
During one of our meetings the YPAG members came
up with the original ideas of creating an animated video
as part of the information study materials and a dedi-
cated MAGIC study website to advertise and showcase
the study. Following the suggestions on what to include
in the website and how to display it, the website https://
www.gastrointestinalmri.org.uk/ was created. The YPAG
has their own space in the website where blogs, com-
ments and photos of the group’s sessions are posted
(having obtained written consent to display the photos
upfront). For the animation video they wrote a script
explaining the rationale behind the study, what was in-
volved for the participants and instructions for the chil-
dren and parents on how to take the mini capsules. The
YPAG suggested the use of the animation video as it
was a more modern way to explain the study to young
participants. They described it as eco-friendly, accessible
using phones and tablets, more memorable than reading
pages of text, and may also help to overcome barriers
with children with learning difficulties.
During a few sessions and with the help of student an-
imators from Nottingham Trent University the group
successfully designed, created, scripted and narrated two
cartoons, now available on You Tube to explain what’s
involved when volunteering for the MAGIC study.
https://youtu.be/luvIutiTvr4 and https://youtu.be/w5
O8lhZqEs8. One further suggestion by the YAPG was to
include a QR code on the patient information sheets,
which linked to the study’s website. The result of the
YPAG involvement here meant information about the
research team (and other studies the research group
were involved in) could be conveyed to the studies target
audience, using a modern approach which the YPAG
could identify with.
The YPAG has also been involved in presenting the
research. One of the Nottingham YPAG members was
invited to speak at the NIHR Biomedical Research
Centre conference in Nottingham in 2019 and two
were invited to speak at the Nottingham Paediatric
Research Showcase. The YPAG members gave a sup-
porting talk to a large audience on the MAGIC study
and their involvement and experiences of PPI. A pos-
ter co-authored by the YPAG was also presented at
the British Paediatric Gastroenterologist Conference
as well as a subsequent Nottingham Paediatric Re-
search Showcase. Lastly, the YPAG contributed and
Fig. 4 Examples of different use of language in the two patient information sheets. a Example from the 7–9 year olds patient information sheet.
b Example from the 16–18 year old patient information sheet
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are formal co-authors on the scientific paper originat-
ing from the MAGIC feasibility clinical study [1] and
of course on this Commentary.
YPAG tasks – follow-on grant application
Finally, the group were introduced to the idea of the
MAGIC2 study and asked to consider the new studies
proposal. They were also asked to think how they
would like to continue to be involved in the future
study. As a result of the YPAG reviewing the MAGI
C2 protocol draft, they noted that the control arm
comprising half of the participants was at a disadvan-
tage compared to the intervention arm. In the ori-
ginal draft, the intervention arm underwent the test
and their clinical team received the transit results so
that the treatment could be reviewed including this
additional new information but the control arm did
not, with the intention of measuring increased treat-
ment success when informed by the new transit test.
The YPAG thought that this put the control arm par-
ticipants to an unfair disadvantage, and as a result of
this discussion we changed the protocol to ensure all
participants, from both arms of the study received
their results, with the only difference that the control
arm will now receive their results but after a standard
delay to allow first an appropriate comparison of
treatment success between the two arms of the study.
The impact of the involvement improved the study
making it fairer for all participants. It is important to
mention that the YPAG members are now invited to
attend as full members of the follow-on NIHR MAGI
C2 study grant quarterly management meetings due
to their valued input throughout the development
process.
Grant funding considerations
At the start of the YPAG’s involvement with the MAGI
C study, the cost of PPI was quantified and 6% of the
grant funding was specifically allocated to NIHR Not-
tingham GenerationR YPAG. These monies were
assigned to cover the cost of PPI involvement and calcu-
lated using standard tariffs which included hiring rooms,
catering, appreciation vouchers for members, equipment
hire and travel costs. The budget was further increased
and approved at the grant stage 2. The percentage of al-
located money available in the grant for PPI involvement
for MAGIC2 is 37% greater than that assigned for
MAGIC, due to the size and complexity of the new
study, but also the increased involvement activities
planned with the YPAG.
Limitations
Our findings are based entirely on the experiences of
the facilitators of the Nottingham GenerationR YPAG
and the MAGIC study researchers. We never
expected the YPAG to be so successful and so influ-
ential on the MAGIC study. Therefore, this Commen-
tary is in narrative format as we did not set out to
capture PPI impact or collect research data. We also
did not collect data on member demographics nor
reasons behind members leaving the group. During
the MAGIC2 study the team plan to rectify this and
address some of the gaps in data that were found
during the writing of this paper. A challenge that was
faced early on was that the YPAG group had to be
paused due to a change in staffing. The YPAG was
managed centrally by the PPI Manager within Re-
search and Innovation Department at Nottingham
University Hospitals. When this staff member left,
there was not the capacity to maintain the group,
which led to a break of 9 months without YPAG
meetings. Management of the group is now spread
across a team, rather than one individual to ensure
sustainability. We would recommend considering the
following to avoid this challenge; how long you would
like the YPAG to be involved for; consider what will
happen if a member/facilitator leaves; ensure there is
adequate staff resource for the full time period of
planned PPI activities.
A further limitation of our account and experience
is our lack of methods for collecting formal feedback
from our group. After each YPAG session feedback
was obtained from those that attended, and used to
continuously improve the YPAG sessions moving for-
ward. However this wealth of data could have been
collected and recorded in a more efficient and in-
depth manner, providing us with qualitative measur-
able evidence of impact. With hindsight this is a
major limitation. If we were to repeat the last 5 years
of involvement with the YPAG, we would put in
place systems to collect considerably more data. Go-
ing forward into MAGIC2 we plan to decide on clear
parameters of what data would be beneficial to col-
lect. On the other hand, one needs also to note that
the willingness of the researchers and the CYP to
work together from the first encounter allowed the
rapport to be built and many positive learning,
change and outcomes to develop as we went along
the journey, humbly and with serendipity.
Reflections
Staley et al. observed experiential knowledge and ex-
perience goes beyond the text book, and the issues
which really matter to them are quite different from
that of the clinicians [27]. Brady and Graham corrob-
orated this statement by explaining understanding
CYP are experts of their own lives, is key to meaning-
ful and effective research [12]. With this in mind, the
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MAGIC study embarked on a relationship with a
group of children and young people back in 2014.
The researchers had a genuine interest in hearing
what a group of young people could contribute to a
project involving children but what the researchers
could not forecast was that the MAGIC partnership
with the Nottingham YPAG would last for more than
5 years and that it would continue to date. Some CYP
moved on and others joined, but to our knowledge
this is a unique example of a sustained collaboration
throughout the life-cycle of one study and the begin-
ning of another. There is a lot to reflect on how the
research was improved by the collaboration with the
YPAG and what we learned from each other.
One possible reason for success is that each YPAG
session was carefully planned with the study team,
based on the stage the research study was at and cor-
responding issues which would benefit from CYP in-
put. The YPAG themselves were asked what activities
they wanted to do at the end of each session, so they
could be planned in for future sessions. This was to
ensure relationships were equal and the work was
meaningful both in terms of the research progress
and beneficial to those involved. The quote below is
from a mother who advocates the YPAG sessions her
daughter has been attending: “I’m so proud of her for
not shying away in a group. YPAG is doing wonders
for her confidence!”
Building rapport with the young people is the key
to their enjoyment and getting the best out of them.
Allowing them to try things out and to make mis-
takes in a safe environment where mistakes are ac-
cepted as part of learning. Play was a big part of
the YPAG sessions. Vygotsky devoted much of his
life’s work to the influence of play for learning [28].
His work often forms the foundation of research
and theory in cognitive development. Vygotsky
theorised that community or collaboration, played a
pivotal role in the “process of making meaning” in a
child’s mind.
Staley and Barron said the quality of the interaction
is more important than the process [16]. This was
exactly true of the ‘pipework gut’ activity. Play, ex-
ploration, the physical construction of a working
model, was a far more fun method of interaction
which was both inclusive and memorable for everyone
involved. Most importantly it suited the needs of this
group of CYP, helping them to make friends with
other group members and facilitators and ultimately
making them feel relaxed and energised to work to-
gether on this study.
Matthews et al. reported that documents intended
for the public are often not written with the public
[29]. PPI provides the opportunity for the public to
have their say and to be viewed by a “fresh-eyed re-
viewer” [30], influencing health care to their bespoke
needs. The combination of clinical experience and de-
velopmental scientists when tackling a problem is not
enough, they must have input from people with first-
hand experience of the condition [16]. The YPAG put
great effort into the writing and reviewing of patient
information sheets, consent forms, assent forms and
health questionnaires. This was purposefully planned
to ensure all documents which would be viewed and
used by the public during the MAGIC study and es-
pecially for children were written in lay terms which
could be understood by all, as well as those with
learning impairments. We also wanted to ensure the
questions asked were relevant to patients, sensitive to
their specific needs which were important to them
most, and not just straight from a textbook. Barker
et al. term this the “critical friend” approach, allowing
the PPI to ask questions which are representative of
their cohort and not of an expert panel [30].
The YPAG was involved in the production of this
manuscript. During the latest meeting we have also
reflected on what questions we could ask to improve
the participation for our future studies. During our
last session with the YPAG we put the question to
them, asking what advice you would give to re-
searchers who were embarking on a study involving
CYP (Appendix 3).
Conclusions
“Co-production” is not a quick process [31]. Plan-
ning, resourcing, staffing, executing PPI meetings
and building rapport with the members is time-
intensive. However, the benefits and insight which
the researchers gained reflected the investment
made in personal time and effort by both parties.
The interactions and their experiential knowledge
brought a level of reality to the study which could
never be replicated from answers on anonymous
questionnaires.
Our case study shows an example of a mutual
partnership between researchers and a group of
CYP that goes beyond theory and focuses on the
patients behind the data. We’ve shown that with the
right combination of involvement from CYP and re-
searchers that it can work in practice too. We
achieved a mutually beneficial partnership between
the YPAG and the MAGIC study researchers. With-
out their contribution we would have missed a
protocol flaw and been poorer in our understanding
of our study participant’s lives. We have shown that
CYP should be involved in research as they are val-
ued members of our society with worthy contribu-
tions and unique insights.
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Appendix 1
YPAG timeline activities, feedback and impact
Table 2 Feedback from the Young Persons Advisory Group (YPAG)
Date Activity Feedback Impact
Sep
2014
The YPAG makes its debut on the MAGIC
grant proposal. The first contact with the
YPAG is mediated by the Clinical Research
Network: East Midlands PPI specialist and
YPAG group convenor
The YPAG agrees to participate in the MAGIC
programme, 5 meetings are planned
throughout the proposed programme,
including meeting the technology
consultants, designers, and participating at a
scientific conference.
MAGIC has 6% of total cost in PPI funding




Split into 3 different groups based on age, 8–
11, 12–15, 16–18.
• Looked at mini capsule design
• Completed tablet design questionnaire
• Built gut transit model using plumbers
plastic piping to educate group on study
concept
The smaller, smooth and rounded shape
design was preferred by all age groups,
stating they would not want special tablet
shape and that these could be difficult to
swallow. Smooth texture would be preferred.
No flavour to tablets as will not be able to
please everyone with a flavour.
When taking the tablets the children should
have a choice about what they take this with.
Recommended milkshake or squash.
Comments on capsules size, shape and
characteristics were fed back to the designers.
The recommendation to swallow the mini-
capsules with something nice such as juice or




• Discussed the Ethics application for
project
• Worked together on the Patient
Information Leaflets
• Updated the YPAG project progress and
described the next steps
Group discussed information leaflets needed
to be different for age ranges, and suggested
that information be divided into 3 different
age brackets.
Advised on wording and format of the
patient information leaflets.
May be more interesting if there was a video
to describe the study.
Feedback from the YPAG led us to produce
different Ethics information sheets divided
into three age appropriate bands.
They also suggested that we produce a video
animation as information sheet, an idea we
are working towards now.
Aug
2016
• Mini capsule packaging design -
Packaging arts and crafts using food boxes
and containers of different sizes and shapes
• Discussed concept of creating cartoon/
videos
• Looked again at study information sheets
Group created packaging designs, which
included splitting the tablets into three
separate parts that children break off - this is
so they would know what tablets had to be
taken each day.
Looked at stacking the containers on top of
each other.




Device designers and technology consultant
working with YPAG to finalise mini capsule
design
• Looked at existing packaging options
based on feedback from last session.
• Reviewed designs produced by
manufacturers based on feedback from the
last session
Group preferred the 3 different containers
that were joined together but could be
broken off.
This would help children know how many
they have to take and on which day.
Can also carry them around with you with
packaging that is smaller.
After session with the YPAG group agreed on
the chosen design with the manufacturers.
Mar
2017
Split into age groups to provide feedback on:
• The value of the vouchers which will be
offered to participants
• Review and provide feedback on the
study advertisement posters
• Answer researchers queries regarding if
participants should be given the option of
receiving a picture of their MRI scan
• Feedback on the number of
questionnaires participants would have to
complete
• Provide a review on the Assent Form
designed for the study
Voucher:
• £20 maximum – If you participate you
don’t go for the money.
• Give a voucher that can be used at
various places, e.g. shopping centres or
give the participants a list of vouchers they
can choose from.
Posters:
• More colours and pictures (the current
pictures are not related)
• Less writing.
• Should have more important information
at the top.
• Add phone number as well as email
address.
The YPAG suggestions on how to answer
certain queries from the REC Ethics, and also
the fact that we were able to say to the REC
that the YPAG had participated in developing
the answers to their queries, have allowed us
to pass the scrutiny and obtain full Ethics
approval hence the consultation has had a
great impact on the research.
Have now incorporated YPAG’s suggestion in
the revised version of study documentation
and in the letter answering the REC Ethics




Students from the Nottingham Trent
University attended a session to discuss the
MAGIC animation video, looking to co-design
the animation and script
Discussion of upcoming oral presentation at
Nottingham Paediatric Research Showcase
Discussion on the need to hold the breath for
short intervals when doing the MRI exam
The young people suggested this would be a
good exercise to spend 5min doing with the
young people who would be having the MRI
scans before they go in.
Breath-hold practice recommended to study
participants
YPAG members Anmol and Heera co-present
with the investigator at the Nottingham
Paediatric Research Showcase and with 2nd
best oral presentation prize
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Table 2 Feedback from the Young Persons Advisory Group (YPAG) (Continued)
Date Activity Feedback Impact
Jul
2017
This session included recording animation
information sheets, where the YPAG members
read from a script they had co-produced for
the animation.
Input into the design of the MAGIC study
website
Some detailed suggestions on how to display
the website.
YPAG member Lexie wrote a blog of the
session with the animation specialist to adapt
and read the scripts
The YPAG provided all the voice to be added
to the animated videos, The website became
a reality https://www.gastrointestinalmri.org.
uk/ Many suggestions for the website were
taken on board and take to the meeting of
the investigator with the website designer
company, including the dedicated YPAG tab




The review of the animation video and
feedback ready for finalisation.
Started to look at script for a second video.
Only small edits proposed, a couple of script
phrases were re-recorded






Update on MAGIC Study:
• Overview of where the project is now and
how the YPAG have helped to date
• Work on the new follow-on grant pro-
posal MAGIC2 starts. Discussed how the
YPAG could be further involved
• Discuss the need to provide a YPAG
paragraph of test for article on NIHR
website
• Discuss poster presentation at British
Paediatric Gastroenterology conference
Initial comments of clinical trial including
control arm need to include the MRI test too
so that no young person would miss out
YPAG member Anmol collects feedback from
the group and writes a paragraph for the
NIHR case study on MAGIC
YPAG support to new grant proposal MAGIC2.
Study protocol changes with second arm
including MRI test with delayed result reading
The YPAG features prominently in the ‘My
research inspiration’ official case study that
MAGIC has been portrayed in on the funder’s
website.
A poster presentation at the British Paediatric
Gastroenterology conference BSPGHAN is
made with YPAG’s authorship
Apr
2019
Progress report from investigator
New device sachet packaging shown
Plans for MAGIC stand at upcoming
community event Wonder
Comments on the new device packaging
collated, mostly positive, suggestion to make
the writing day 1 / day 2 / day 3 on the pots
more prominent
Looked at possible study memento / mascot
we could buy
Authorship of posters and co-presentation
opportunity discussed and approved
Feedback on new sachet packaging typed up
and shared with manufacturer, labelling of
pots have changed as a result.
YPAG member Olivia co-presents with the in-




Report back from success of MAGIC stand at
Wonder community festival
Focus on the start of MAGIC2 project and
YPAG involvement
YPAG representation on project management
group
YPAG member Pavan writes a blog YPAG’s blog uploaded to the study website.
MAGIC becomes a NIHR Collaboration for
Innovation case study on the NIHR website.
A YPAG member attends the project’s kick-off





Answer specific questions on ethics sheets
from the Clinical Trials Unit
Look at study memento / mascot for study
participants
A number of suggestions for improvement of
the Ethics info sheets for the new MAGIC2
clinical trial are collected, including the use of
QR codes, the addition of a certificate of
participation and a separate, personal bowel
diary to avoid embarrassment when
discussing toilet habits
The YPAG’s suggestions are shared with the
clinical trial unit to modify the information
sheets for Ethics approval.
MAGIC2 has 4% of total cost in PPI funding
(£46,755 over a grant total of £1,186,572) in
the budget. Funding for MAGIC2 PPI is
increased 37% compared to MAGIC.
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Appendix 2
Transcript of YPAG semi-structured interview carried out
in 2019
Transcript of the young persons advisory group semi-
structured interview, with the age of the members answer-
ing the questions in brackets
Interviewer: We have been here since 2014 with the
YPAG. You have been promoting and designing our re-
search so it is nice to be able to share our experiences
over the past 5 years. Firstly can we go round and each
share your impressions and opinions of what it has been
like to be involved in the MAGIC Project?
YPAG Member (11 years old): It’s exciting to see the
research developing, as the advisory group are a wide
age range, I’ve really enjoying being involved and con-
tributing to the design of the information leaflets and
ethics materials.
Interviewer: What do you think about your breadth of
involvement from assisting in designing the device to
disseminating, to sitting on the management boards –
do you feel like you’re doing something important?
YPAG Member (11 years old): It feels like we’re
doing something important and its fascinating to know
that people very young can help and talk to scientists
and people of all age ranges can partake in research and
further develop these ideas.
Interviewer: Do these old and important researchers
know what they are doing, shall they assume that they
know what children want?
YPAG Member (15 years old): I think being part of
research is making sure that patients are pleased and
satisfied with how the research is going.
YPAG Member (17 years old): I think it’s great that
we get to meet new people and see our efforts put to
good use.
Interviewer: How can we spread the message of
research?
YPAG Member (16 years old): By going to schools
and colleges, I think not a lot of people know that
groups like the YPAG exists – when we tell people
we are going to QMC people are like where are you
going what are you doing? And we tell them what
we are doing they are really surprised as they don’t
think that people our age could be involved in re-
search and researchers who are doing such import-
ant work – people don’t know that they have that
opportunity.
Interviewer: Has this changed your view on what you
think you might do when you grow up?
YPAG Member (11 years old): I would like to be a
microbiologist and by taking part in the MAGIC study I
feel it has helped me a lot as it has shown me the steps
you may have to go through when developing a medical
device.
Interviewer: What do you think about the YPAG
meetings?
YPAG Member (15 years old): I like the fact that
we are doing quite a lot for research as young
people who think like the patients and we think
from the patient’s perspective rather than the profes-
sional’s world – so it’s great to think we are helping
the patients.
YPAG Member (16 years old): Being part of the
YPAG helps you to have an insight into the other
side of things – as young people we go to the doc-
tor and get medicine and we don’t see how that
medicine comes to be or any of that process. So I
think I understand a lot more about how things
happen.
YPAG Member (17 years old): We share our
thoughts and its good how we can share our perspec-
tives and evaluate and discuss pros and cons – it’s a
good experience.
YPAG Member (17 years old): It’s good to be actually
involved in a study – it’s good to interact with other
people and develop yourself.
YPAG Member (15 years old): I think there are a lot
of things that are changed because of the YPAG.
YPAG Member (12 years old): I think our ideas are
really getting used and I think people would be sur-
prised at how many ideas from CYP are being used
in research and its really thinking that you can actu-
ally help people.
Interviewer: What is your favourite moment of the
YPAG?
YPAG Member (16 years old): I think when we got
to design the pills choosing the shape and the size
using different boxes and colours was my favourite
activity.
YPAG Member (12 years old): There are different ac-
tivities and studies every time we meet – when you get
to say what you want to say- before the YPAG I didn’t
have the chance to say what I wanted to say about med-
ical health.
YPAG Member (17 years old): I was quite shy when I
started but then you get to know everyone and you feel
comfortable.
YPAG Member (15 years old): There is always a
chance to interact with others with ice breakers that are
fun but also professionals.
YPAG Member (16 years old): We helped create a
video to help advertise the MAGIC Study that we got to
voice over and we publish our findings on social media
and on the MAGIC website.
YPAG Member (12 years old): I think it’s a good idea
for young people to share their thoughts as it can leads
to improvements and change their perspective on
everything.
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Appendix 3
Notes from the 11th June virtual YPAG meeting
Table 3 Feedback from the Young Persons Advisory Group (YPAG) on this manuscript, on the impact of the involvement, and
advice for other researchers on how to involve effectively children and young people in research. This feedback was provided at the
YPAG meeting following the completion of the manuscript draft and just before submission to the journal
Discussion Topic Considerations
Plain English Summary Feedback • Well written
• Really nice to see our involvement written out in a paper – validation of our involvement and that it is
respected and taken on board – that it is taken seriously (15 years)
• I don’t think I’ve ever seen our involvement written down like this, it’s amazing to see (15 years)
• Not hard to understand, no challenging words, a good overall summary of the YPAGs involvement. (16
years)
• I can’t believe we’ve been working on the MAGIC Study for 5 years! It doesn’t seem like 5 years! (16 years)
• It’s a very good overview (12 years)
Abstract • Thought the abstract provided a good overview (12 years)
• I liked the abstract and the sub-headings – made it easy to follow (15 years)
How has involvement in the YPAG
Impacted you?
• CONFIDENCE






• LEARNT A LOT
• PROUD
• PART OF A TEAM
• LEARNING JOURNEY
Advice for Researchers • Do not be patronizing – the relationship needs to be equal, and built on respecting each other.
• Come to the YPAG with an open mind – if you come to the group without listening and taking our ideas
on board there is no point coming – do not attend to just tick a box!
• Need to make sure they do not underestimate the YPAG and what we can do and contribute.
• Take everyone’s point of view on board and not just your own – listen to us!
• Be prepared and expect a large variety of opinions and take these on board.
• Come to the YPAG as early as possible for us to be involved – at concept – and keep coming back.
• My top piece of advice is to keep engaged with the young people. If we are kept in the loop of what’s
happening throughout the study, we’ll be thinking about it more regularly- therefore understanding the
study much better and giving us more ideas for comments to help improve the study.
• Make it fun and creative. I like the idea of having an agenda so we know what to expect and also keeping
us updated with any changes and the progress of their research like the MAGIC study
• Spend as much time in the meetings and come back as much as possible, try not to come just once
Abrehart et al. Research Involvement and Engagement             (2021) 7:2 Page 14 of 15
Received: 30 June 2020 Accepted: 30 November 2020
References
1. Sharif H, Abrehart N, Hoad CL, Murray K, Perkins AC, Smith M, et al.
Feasibility study of a new MRI mini-capsule device to measure whole gut
transit time in pediatric constipation. J Ped Gastroenterol Nutr. 2020: in
press. https://doi.org/10.1097/MPG.0000000000002910.
2. Yong D, Beattie RM. Normal bowel habit and prevalence of constipation in
primary school children. Ambul Child Health. 1998;4:277–82.
3. Afzal NA, Tighe MP, Thomson MA. Constipation in children. Ital J Pediatr.
2011;37:28. https://doi.org/10.1186/1824-7288-37-28.
4. van den Berg MM, Benninga MA, Di Lorenzo C. Epidemiology of childhood
constipation: a systematic review. Am J Gastroenterol. 2006;101:2401–9.
https://doi.org/10.1111/j.1572-0241.2006.00771.x.
5. Robin SG, Keller C, Zwiener R, Hyman PE, Nurko S, Saps M, et al. Prevalence
of pediatric functional gastrointestinal disorders utilizing the Rome IV
criteria. J Pediatr. 2018;195:134–9. https://doi.org/10.1016/j.jpeds.2017.12.012.
6. Scarpato E, Kolacek S, Jojkic-Pavkov D, Konjik V, Zivkovic N, Roman E, et al.
Prevalence of functional gastrointestinal disorders in children and
adolescents in the mediterranean region of Europe. Clin Gastroenterol
Hepatol. 2018;16:870–6. https://doi.org/10.1016/j.cgh.2017.11.005.
7. NICE. Costing report. Constipation in children and yound people.
Implementing NICE guidance. Clinical Guideline 99. 2010.
8. Liem O, Harman J, Benninga M, Kelleher K, Mousa H, Di Lorenzo C. Health
utilization and cost impact of childhood constipation in the United States. J
Pediatr. 2009;154:258–62. https://doi.org/10.1016/j.jpeds.2008.07.060.
9. Benninga MA, Nurko S, Faure C, Hyman PE, Roberts IS, Schechter NL.
Childhood functional gastrointestinal disorders: neonate/toddler.
Gastroenterology. 2016;150:1443–55. https://doi.org/10.1053/j.gastro.2016.
02.016.
10. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M.
Childhood functional gastrointestinal disorders: child/adolescent.
Gastroenterology. 2016;150:1456–68. https://doi.org/10.1053/j.gastro.2016.
02.015.
11. Metcalf AM, Phillips SF, Zinsmeister AR, Maccarty RL, Beart RW, Wolff BG.
Simplified assessment of segmental colonic transit. Gastroenterology. 1987;
92:40–7. https://doi.org/10.1016/0016-5085(87)90837-7.
12. Brady L-M, Graham B. Social research with children and young people a
practical guide. Bristol: Policy Press Shorts; 2019.
13. Treseder P. Empowering children and young people. Training manual:
promoting involvement in decision making.: Children’s Rights Office. Save
the Children Fund; 1997.
14. Shier H. Pathways to participation: openings, opportunititees and
obligations. Child Soc. 2001;15:107–17. https://doi.org/10.1002/chi.617.
15. Hart RA. Children’s participation: from tokenism to citizenship. Florence:
UNICEF International Children Development Centre; 1992.
16. Staley K, Barron D. Learning as an outcome of involvement in research:
what are the implications for practice, reporting and evaluation? Res Involv
Engagem. 2019;5:14. https://doi.org/10.1186/s40900-019-0147-1.
17. Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, et al.
Mapping the impact of patient and public involvement on health and
social care research: a systematic review. Health Expect. 2014;17:637–50.
https://doi.org/10.1111/j.1369-7625.2012.00795.x.
18. Winch R, McColgan MP, Sparrow E, Modi N, Greenough A. Public and
patient involvement in child health research and service improvements: a
survey of hospital doctors. BMJ Paediatr Open. 2018;17:e000206. https://doi.
org/10.1136/bmjpo-2017-000206.
19. Fleming J, Boeck T. Involving Children and Young People in health and
social care research: Routledge; 2013.
20. Riggare S, Stecher B, Stamford J. Patient advocates respond to ‘utilizing
patient advocates … ’ by Feeney et al. Health Expect. 2020;23:972–3.
https://doi.org/10.1111/hex.13087.
21. Mayall B. Children’s rights and the sociology of childhood. In:
Vandenhole W, Desmet E, Reynaert D, Lembrechts S, editors. The
Routledge International Handbook of Children’s Rights Studies:
Routledge; 2015. p. 77–93.
22. Parsons S, Thomson W, Cresswell K, Starling B, McDonagh JE, Barbara Ansell
Natl Network A. What do young people with rheumatic disease believe to
be important to research about their condition? A UK-wide study. Pediatr
Rheumatol. 2017;15:53. https://doi.org/10.1186/s12969-017-0181-1.
23. Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, et al.
GRIPP2 reporting checklists: tools to improve reporting of patient and
public involvement in research. BMJ. 2017;358:j3453. https://doi.org/10.
1136/bmj.j3453.
24. Ocloo J, Matthews R. From tokenism to empowerment: progressing patient
and public involvement in healthcare improvement. BMJ Quality Safety.
2016;25:626–32. https://doi.org/10.1136/bmjqs-2015-004839.
25. Poland F, Charlesworth G, Leung PC, Birt L. Embedding patient and public
involvement: managing tacit and explicit expectations. Health Expect. 2019;
22:1231–9. https://doi.org/10.1111/hex.12952.
26. Hart RA. Stepping back from ‘the ladder of participation’: reflections on a
model of children's engagement in group activities. In: Jensen B, Reid A,
editors. Progress in participatory research with children and youth. Newbury
Park: Sage; 2008.
27. Staley K, Abbey-Vital I, Nolan C. The impact of involvement on researchers: a
learning experience. Res Involv Engagem. 2017;3:20. https://doi.org/10.1186/
s40900-017-0071-1.
28. McLeod SA. Lev Vygotsky Sociocultural Theory. Simply Psychology. 2018.
Available from: https://www.simplypsychology.org/vygotsky.html.
29. Matthews R, Kaur M, French C, Baker A, Reed J. How helpful are patient and
public involvement strategic documents - results of a framework analysis
using 4Pi National Involvement Standards. Res Involv Engagem. 2019;5:31.
https://doi.org/10.1186/s40900-019-0164-0.
30. Barker J, Moule P, Evans D, Phillips W, Leggett N. Developing a typology of
the roles public contributors undertake to establish legitimacy: a
longitudinal case study of patient and public involvement in a health
network. BMJ Open. 2020;10:e033370. https://doi.org/10.1136/bmjopen-
2019-033370.
31. Dewa LH, Lawrence-Jones A, Crandell C, Jacques J, Pickles K, Lavelle M,
et al. Reflections, impact and recommendations of a co-produced
qualitative study with young people who have experience of mental health
difficulties. Health Expect. 2020;13088. https://doi.org/10.1111/hex.13088.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Abrehart et al. Research Involvement and Engagement             (2021) 7:2 Page 15 of 15
